We don’t have any new products on the market to talk about, but we are going to discuss the approval of the combination Opdivo and Yervoy for treating mesothelioma, and new indication approvals for Nucala and Xeljanz. We'll also talk about a new age group for Kalydeco for treating cystic fibrosis. Don't forget to like, share, and subscribe! Enjoy!